Showing results (71-80 of 4,345) with videos related to
Sort By:
Pageof 435
Surgery|May 1, 1979
Chemotherapy of gastric and pancreatic carcinoma: a controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and "lactones"C G Moertel, P Engstrom, P T Lavin, et al.Cancer Treatment Reports|March 1, 1978
Phase II study of metronidazole therapy for advanced colorectal carcinomaS Frytak, C G Moertel, D S Childs, et al.American Journal of Clinical Oncology|June 1, 1986
Clinical trial of cisplatin and intensive course 5-fluorouracil for the treatment of advanced colorectal cancerM J O'Connell, C G Moertel, L K Kvols, et al.American Journal of Clinical Oncology|October 1, 1984
A phase II study of the combination, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and N-(phosphonacetyl)-L-aspartate (PALA), in patients with advanced large bowel cancerJ Rubin, A J Schutt, M J O'Connell, et al.Cancer Chemotherapy and Pharmacology|January 1, 1981
Pharmacology of amygdalin (laetrile) in cancer patientsM M Ames, T P Moyer, J S Kovach, et al.Cancer|September 15, 1984
Primary liver cancer. An Eastern Cooperative Oncology Group TrialG Falkson, J M MacIntyre, C G Moertel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1986
A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomasC G Moertel, J Rubin, M J O'Connell, et al.Endocrine-Related Cancer|March 24, 2000
Combination hormonal therapy involving aromatase inhibitors in the management of women with breast cancerJ N Ingle, V J Suman, V C Jordan, et al.Controlled Clinical Trials|June 1, 1988
A design for phase II testing of anticancer agents within a phase III clinical trialD J Schaid, J N Ingle, S Wieand, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1985
Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group studyD J Klaassen, J M MacIntyre, G E Catton, et al.Pageof 435